MORE►
Institute for Translational Research
Photo: UNT Health Fort Worth
The Last Word: UNT Health FW Gets $6.8M for Alzheimer’s Study on Adults With Down Syndrome
by David Seeley | May 28, 2026
Studies show the lifetime incidence of Alzheimer’s disease among adults with Down syndrome is 90%. Researchers called the national ABC-DS study "especially timely" as more treatment options for Alzheimer’s disease are found and more clinical trials are launched for adults with Down syndrome.
by Sandra Engelland |
May 28, 2026
Studies show the lifetime incidence of Alzheimer’s disease among adults with Down syndrome is 90%. Researchers called the national ABC-DS study "especially timely" as more treatment options for Alzheimer’s disease are found and more clinical trials are launched for adults with Down syndrome.
MORE►
by Kevin Cummings |
Oct 3, 2022
The funding from the National Institutes of Health will help UNT HSC at Fort Worth advance its ongoing research on how Alzheimer's disease affects different racial and ethnic groups. Sid O'Bryant, executive director of UNT HSC's Institute for Translational Research, said there's never been a large-scale study like this before.
“This award and project are nothing short of a bio behavioral ‘moonshot’ program," adds Brian Gladue, HSC executive VP for research and innovation.
MORE►
by Sandra Engelland |
Mar 16, 2021
Contracting Alzheimer's is the No. 1 fear of people over 65, says Sid O'Bryant, who wants to give primary physicians the ability to test for Alzheimer's with a blood test. That can offer peace of mind to many and earlier help for those who need it.
His groundbreaking research, which has revealed significant differences in biomarkers for the disease, could make the treatment of Alzheimer's more like that for cancer—a multi-dimensional "precision" approach.
His groundbreaking research, which has revealed significant differences in biomarkers for the disease, could make the treatment of Alzheimer's more like that for cancer—a multi-dimensional "precision" approach.
MORE►
